Johnson & Johnson is pulling two product strains as soon as promoted as dark-spot reducers that had been popularly used to lighten pores and skin, the corporate has introduced.
The pharmaceutical big and producer will now not be promoting its Clear & Clear Equity line in India and Neutrogena Advantageous Equity line in Asia and the Middle East, a spokesperson confirmed to Fox Information on Monday.
TWITTER RESPONDS TO BAND-AID’S NEW BANDAGES FOR DIVERSE SKIN TONES: ‘TOOK LONG ENOUGH’
Calls to take away products, manufacturers and logos with problematic histories and racist connotations have swept the globe following the Memorial Day dying of George Floyd in police custody.
“Conversations over the past few weeks highlighted that some product names or claims on our dark spot reducer products represent fairness or white as better than your own unique skin tone,” Johnson & Johnson mentioned in a press release. “This was never our intention – healthy skin is beautiful skin.”
The corporate will now not be producing or transport the Clear & Clear Equity or Neutrogena Advantageous Equity lotions, J&J mentioned.
“Our website and retailer pages are being updated now to remove links to purchase. For a short while products may still appear on a limited number of in-store shelves as stock runs through,” the spokesperson defined.
Neither product line was sold in the U.S., they added.
CLICK HERE FOR FOX NEWS’ CONTINUING CORONAVIRUS COVERAGE
The Johnson & Johnson-owned Band-Support model additionally lately introduced it will be creating new bandages to match extra various pores and skin tones — although some social media commenters criticized the corporate for taking so lengthy to take action.